Filing Flows › OptimizeRx (OPRX) › Q1 2025
OptimizeRx (OPRX) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 13, 2025
OptimizeRx (OPRX) reported revenue of $21.9M for the first quarter 2025 (Q1 2025), +11% from a year earlier and -32% from the quarter before. Operating margin was -9.6%, net loss $2.2M (10.0% of revenue).
OptimizeRx, Q1 2025: revenue $21.9M (+11% year over year), operating margin -9.6%, net loss $2.2M, operating cash flow $3.9M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $21.9M | -32% | +11% |
| Operating profit | −$2.1M | -158% | — |
| Net earnings | −$2.2M | — | — |
| Operating cash flow | $3.9M | 20× | +82% |
| Free cash flow | $3.8M | 21× | +84% |
What changed
Revenue was $21.9M in Q1 2025, up 11% year over year and down 32% from the previous quarter.
Gross margin was 60.9%, down 1.1 points from a year earlier. Operating costs exceeded revenue by $2.1M, an operating margin of -9.6%. Operating expenses fell 10% while revenue rose 11%. The quarter ended with a net loss of $2.2M, wider than the previous quarter's $78K loss. Net interest and other expense of $1.2M was the main reason.
Operating cash flow was $3.9M (up 82% year over year). Non-cash charges added back $1.1M of depreciation and amortization and $1.6M of share-based compensation. Working capital and other items added $3.4M. Capital expenditures of $27K left free cash flow of $3.8M.
Questions
What was OptimizeRx's revenue in the first quarter 2025?
OptimizeRx (OPRX) reported revenue of $21.9M for the first quarter 2025 (Q1 2025), +11% from a year earlier and -32% from the quarter before.
Was OptimizeRx profitable in the first quarter 2025?
Operating loss was $2.1M (-9.6% of revenue) and net loss $2.2M.
Source: OptimizeRx 10-Q on SEC EDGAR.